Rising Thanksgiving Commodity Costs Gobbling Up Wallets
By Scott Bauer
Loading...
Video Player is loading.
Current Time 0:00
Duration -:-
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x

 

If supply chain issues and drought weren’t enough, a severe case of avian flu has added to the turkey shortage. According to the Centers for Disease Control and Prevention, since early 2022, more than 49 million birds in 46 states have either died because of bird flu virus infection or have been culled (killed) due to exposure to infected birds. That includes over 6 million turkeys.

In addition, the ongoing war between Ukraine and Russia has spillover effects on grocery items in the United States. Ukraine is a large exporter of grains and vegetable oil products, and with a shortage of supply, consumers are paying as much as 32% more for butter and margarine products than last year.

And last, but not least, is the inflation problem. All retail food prices were 21% higher in September compared to the same time last year but dropped somewhat in October. When it comes to Thanksgiving specifically, analysts say year-over-year cost increases in eggs (up 32.5%), butter (up 25.8%) and flour (up 17.1%) are some of the biggest contributors to the overall price jump consumers are facing when buying ingredients for Thursday’s big meal. 

Loading...

About the author

Scott Bauer
Scott Bauer, CEO, Prosper Trading Company

Scott Bauer graduated with honors from the University of Illinois Business School, Urbana Champaign, in 1988 with a B.S. in Finance. Bauer began floor trading in 1991 and formed BOTTA Capital Management in 1995. Scott traded equity options, S&P options at CME and was employed by Goldman, Sachs & Co. as Vice-President, Equities Division. He is currently CEO of Prosper Trading Academy and appears regularly on CNBC, Bloomberg Financial and Fox Business as a guest commentator.

 

 

OpenMarkets is an online magazine and blog focused on global markets and economic trends. It combines feature articles, news briefs and videos with contributions from leaders in business, finance and economics in an interactive forum designed to foster conversation around the issues and ideas shaping our industry.

All examples are hypothetical interpretations of situations and are used for explanation purposes only. The views expressed in OpenMarkets articles reflect solely those of their respective authors and not necessarily those of CME Group or its affiliated institutions. OpenMarkets and the information herein should not be considered investment advice or the results of actual market experience. Neither futures trading nor swaps trading are suitable for all investors, and each involves the risk of loss. Swaps trading should only be undertaken by investors who are Eligible Contract Participants (ECPs) within the meaning of Section 1a(18) of the Commodity Exchange Act. Futures and swaps each are leveraged investments and, because only a percentage of a contract’s value is required to trade, it is possible to lose more than the amount of money deposited for either a futures or swaps position. Therefore, traders should only use funds that they can afford to lose without affecting their lifestyles and only a portion of those funds should be devoted to any one trade because traders cannot expect to profit on every trade. BrokerTec Americas LLC (“BAL”) is a registered broker-dealer with the U.S. Securities and Exchange Commission, is a member of the Financial Industry Regulatory Authority, Inc. (www.FINRA.org), and is a member of the Securities Investor Protection Corporation (www.SIPC.org). BAL does not provide services to private or retail customers.. In the United Kingdom, BrokerTec Europe Limited is authorised and regulated by the Financial Conduct Authority. CME Amsterdam B.V. is regulated in the Netherlands by the Dutch Authority for the Financial Markets (AFM) (www.AFM.nl). CME Investment Firm B.V. is also incorporated in the Netherlands and regulated by the Dutch Authority for the Financial Markets (AFM), as well as the Central Bank of the Netherlands (DNB).

©2025 CME Group Inc. All rights reserved